GGrantIndex
← Leaderboards

Manuela Raffatellu

University Of California-Irvine

$10,626,800
Attributed
$15,652,713
Total exposure
14
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,652,713 · 14

By mechanism

R01$10,942,076 · 5
R21$2,932,542 · 7
R37$1,378,574 · 1
R56$399,521 · 1

Top collaborators

Most similar at University Of California-Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Pathogen

Research focus

PathogenInfectionSalmonellaAntimicrobialIronSalmonella TyphimuriumInflammatoryEnvironmentBacteriaSalmonella InfectionsDiarrheaMucous MembraneMediatingExpectationImmune ResponseBacterial InfectionsBaseUnited StatesBacteremiaNutrientEscherichia ColiInflammationMorbidity - Disease RateMicrobiota

Grant awards (47)

Harnessing iron acquisition to hinder enterobacterial pathogenesis$635,769
R01 · FY2025 · AI · contact PI
Nutritional immunity during Salmonella infection$456,731
R37 · FY2025 · AI · contact PI
Applied Metatranscriptomics and Metatranslatomics to identify new mechanisms of Salmonella-microbiota competition$178,331
R21 · FY2025 · AI · contact PI
Harnessing iron acquisition to hinder enterobacterial pathogenesis$92,728
R01 · FY2025 · AI · contact PI
Harnessing iron acquisition to hinder enterobacterial pathogenesis$655,212
R01 · FY2024 · AI · contact PI
Nutritional immunity during Salmonella infection$459,562
R37 · FY2024 · AI · contact PI
Applied Metatranscriptomics and Metatranslatomics to identify new mechanisms of Salmonella-microbiota competition$223,997
R21 · FY2024 · AI · contact PI
Harnessing iron acquisition to hinder enterobacterial pathogenesis$91,121
R01 · FY2024 · AI · contact PI
Harnessing iron acquisition to hinder enterobacterial pathogenesis$669,498
R01 · FY2023 · AI · contact PI
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial Pathogenesis$626,584
R01 · FY2023 · AI · contact PI
Nutritional immunity during Salmonella infection$462,281
R37 · FY2023 · AI · contact PI
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial Pathogenesis$627,952
R01 · FY2022 · AI · contact PI
Harnessing iron acquisition to hinder enterobacterial pathogenesis$399,521
R56 · FY2022 · AI · contact PI
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial Pathogenesis$628,647
R01 · FY2021 · AI · contact PI
Antimicrobial activity of Escherichia coli Nissle 1917 microcin M$193,800
R21 · FY2021 · AI · contact PI
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial Pathogenesis$628,663
R01 · FY2020 · AI · contact PI
Nutritional immunity during Salmonella infection$387,500
R01 · FY2020 · AI · contact PI
Antimicrobial activity of Escherichia coli Nissle 1917 microcin M$246,485
R21 · FY2020 · AI · contact PI
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial Pathogenesis$629,334
R01 · FY2019 · AI · contact PI
Nutritional immunity during Salmonella infection$387,500
R01 · FY2019 · AI · contact PI
Development of siderophore-based vaccines against non-typhoidal Salmonella infection$372,657
R01 · FY2019 · AI · contact PI
Nutritional immunity during Salmonella infection$387,500
R01 · FY2018 · AI · contact PI
Development of siderophore-based vaccines against non-typhoidal Salmonella infection$373,468
R01 · FY2018 · AI · contact PI
Nutritional immunity during Salmonella infection$262,068
R01 · FY2017 · AI · contact PI
Development of siderophore-based vaccines against non-typhoidal Salmonella infection$258,094
R01 · FY2017 · AI · contact PI
Siderophore-based antibiotics: consequences for the microbiota and bacterial pathogens$175,161
R21 · FY2017 · AI
The new chemokine CCL28 and its role during Salmonella infection$151,939
R21 · FY2017 · AI · contact PI
Development of siderophore-based vaccines against non-typhoidal Salmonella infection$130,293
R01 · FY2017 · AI · contact PI
Nutritional immunity during Salmonella infection$115,498
R01 · FY2017 · AI · contact PI
The new chemokine CCL28 and its role during Salmonella infection$41,318
R21 · FY2017 · AI · contact PI
Nutritional immunity during Salmonella infection$377,261
R01 · FY2016 · AI · contact PI
Development of siderophore-based vaccines against non-typhoidal Salmonella infection$364,603
R01 · FY2016 · AI · contact PI
The new chemokine CCL28 and its role during Salmonella infection$231,750
R21 · FY2016 · AI · contact PI
Siderophore-based antibiotics: consequences for the microbiota and bacterial pathogens$228,963
R21 · FY2016 · AI
Development of siderophore-based vaccines against non-typhoidal Salmonella infection$353,978
R01 · FY2015 · AI · contact PI
The role of the circadian clock during Salmonella infection$193,125
R21 · FY2015 · AI · contact PI
Targeting iron acquisition in Salmonella with siderophore-based immunization$183,880
R21 · FY2015 · AI · contact PI
Mucosal barrier function during Salmonella infection$365,933
R01 · FY2014 · AI · contact PI
Targeting iron acquisition in Salmonella with siderophore-based immunization$233,642
R21 · FY2014 · AI · contact PI
The role of the circadian clock during Salmonella infection$231,313
R21 · FY2014 · AI · contact PI
Mucosal barrier function during Salmonella infection$377,058
R01 · FY2013 · AI · contact PI
Mucosal barrier function during Salmonella infection$368,870
R01 · FY2012 · AI · contact PI
Mucosal barrier function during Salmonella infection$33,574
R01 · FY2012 · AI · contact PI
Mucosal barrier function during Salmonella infection$370,074
R01 · FY2011 · AI · contact PI
Mucosal barrier function during Salmonella infection$370,639
R01 · FY2010 · AI · contact PI
Metal withholding responses in the gut mucosa$189,338
R21 · FY2010 · AI · contact PI
Metal withholding responses in the gut mucosa$229,500
R21 · FY2009 · AI · contact PI